MedPath

Study to determine the relative level of insulin resistance and defect in insulin secretion in diabetic patients of different body habitus.

Not Applicable
Conditions
Health Condition 1: E11- Type 2 diabetes mellitus
Registration Number
CTRI/2022/02/040316
Lead Sponsor
Dr Sarin S M
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Open to Recruitment
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Recent detected ( <5yrs duration) Type 2 Diabetic patients diagnosed based on ADA 2010 criteria in the age group >30 years in Kannur District, Kerala.

Exclusion Criteria

1)Patients having Chronic Kidney Disease with GFR <60ml/min/1.73m2

2)Patients diagnosed with Chronic liver disease, chronic Infections and Malignancy.

3)Patients who are using insulin for treatment.

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
1)Body mass index <br/ ><br>2)Beta cell dysfunction(calculated as HOMA-%B) and insulin resistance (calculated as HOMA-IR)Timepoint: 1)Body mass index - baseline <br/ ><br>2)Beta cell dysfunction(calculated as HOMA-%B) and insulin resistance (calculated as HOMA-IR) - baseline
Secondary Outcome Measures
NameTimeMethod
Waist circumference <br/ ><br>Waist Hip ratio <br/ ><br>Prevalence of Lean, normal body weight and overweight among type 2 DMTimepoint: Baseline
© Copyright 2025. All Rights Reserved by MedPath